ÂÜÀòÂÒÂ×

Andrew Jackson, MBA, has extensive experience in strategy and product marketing, currently serving as Director at Milliman. Prior roles include Management Consultant at OptumInsight (UnitedHealth Group) and Business Analyst within the same organization. Andrew's background in the pharmaceutical industry includes positions as Senior Associate Scientist in Medicinal Chemistry at Merck and Cubist Pharmaceuticals, as well as Associate Scientist II roles at both Merck and ItherX Inc. Andrew's academic credentials feature ongoing studies at the University of Minnesota - Carlson School of Management and previous education at WU (Vienna University of Economics and Business).